Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Medicine for Osteoarthritis Pain Market Size Growth Rate by Type
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Market Segment by Application
1.4.1 Global Medicine for Osteoarthritis Pain Market Share by Application (2018-2025)
1.4.2 Medical Care
1.4.3 Personal Care
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medicine for Osteoarthritis Pain Market Size
2.1.1 Global Medicine for Osteoarthritis Pain Revenue 2013-2025
2.1.2 Global Medicine for Osteoarthritis Pain Sales 2013-2025
2.2 Medicine for Osteoarthritis Pain Growth Rate by Regions
2.2.1 Global Medicine for Osteoarthritis Pain Sales by Regions 2013-2018
2.2.2 Global Medicine for Osteoarthritis Pain Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Medicine for Osteoarthritis Pain Sales by Manufacturers
3.1.1 Medicine for Osteoarthritis Pain Sales by Manufacturers 2013-2018
3.1.2 Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Medicine for Osteoarthritis Pain Revenue by Manufacturers (2013-2018)
3.2.2 Medicine for Osteoarthritis Pain Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Medicine for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.3 Medicine for Osteoarthritis Pain Price by Manufacturers
3.4 Key Manufacturers Medicine for Osteoarthritis Pain Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Medicine for Osteoarthritis Pain Market
3.6 Key Manufacturers Medicine for Osteoarthritis Pain Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Sales and Revenue (2013-2018)
4.1.2 Injection Sales and Revenue (2013-2018)
4.1.3 External Sales and Revenue (2013-2018)
4.2 Global Medicine for Osteoarthritis Pain Sales Market Share by Type
4.3 Global Medicine for Osteoarthritis Pain Revenue Market Share by Type
4.4 Medicine for Osteoarthritis Pain Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Medicine for Osteoarthritis Pain Sales by Application
6 North America
6.1 North America Medicine for Osteoarthritis Pain Breakdown Data by Company
6.2 North America Medicine for Osteoarthritis Pain Breakdown Data by Type
6.3 North America Medicine for Osteoarthritis Pain Breakdown Data by Application
6.4 North America Medicine for Osteoarthritis Pain Breakdown Data by Countries
6.4.1 North America Medicine for Osteoarthritis Pain Sales by Countries
6.4.2 North America Medicine for Osteoarthritis Pain Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Medicine for Osteoarthritis Pain Breakdown Data by Company
7.2 Europe Medicine for Osteoarthritis Pain Breakdown Data by Type
7.3 Europe Medicine for Osteoarthritis Pain Breakdown Data by Application
7.4 Europe Medicine for Osteoarthritis Pain Breakdown Data by Countries
7.4.1 Europe Medicine for Osteoarthritis Pain Sales by Countries
7.4.2 Europe Medicine for Osteoarthritis Pain Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Medicine for Osteoarthritis Pain Breakdown Data by Company
8.2 Asia Pacific Medicine for Osteoarthritis Pain Breakdown Data by Type
8.3 Asia Pacific Medicine for Osteoarthritis Pain Breakdown Data by Application
8.4 Asia Pacific Medicine for Osteoarthritis Pain Breakdown Data by Countries
8.4.1 Asia Pacific Medicine for Osteoarthritis Pain Sales by Countries
8.4.2 Asia Pacific Medicine for Osteoarthritis Pain Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Medicine for Osteoarthritis Pain Breakdown Data by Company
9.2 Central & South America Medicine for Osteoarthritis Pain Breakdown Data by Type
9.3 Central & South America Medicine for Osteoarthritis Pain Breakdown Data by Application
9.4 Central & South America Medicine for Osteoarthritis Pain Breakdown Data by Countries
9.4.1 Central & South America Medicine for Osteoarthritis Pain Sales by Countries
9.4.2 Central & South America Medicine for Osteoarthritis Pain Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Medicine for Osteoarthritis Pain Breakdown Data by Type
10.2 Middle East and Africa Medicine for Osteoarthritis Pain Breakdown Data by Application
10.3 Middle East and Africa Medicine for Osteoarthritis Pain Breakdown Data by Countries
10.3.1 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Countries
10.3.2 Middle East and Africa Medicine for Osteoarthritis Pain Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.1.4 Medicine for Osteoarthritis Pain Product Introduction
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.2.4 Medicine for Osteoarthritis Pain Product Introduction
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.3.4 Medicine for Osteoarthritis Pain Product Introduction
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.4.4 Medicine for Osteoarthritis Pain Product Introduction
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.5.4 Medicine for Osteoarthritis Pain Product Introduction
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.6.4 Medicine for Osteoarthritis Pain Product Introduction
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.7.4 Medicine for Osteoarthritis Pain Product Introduction
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.8.4 Medicine for Osteoarthritis Pain Product Introduction
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.9.4 Medicine for Osteoarthritis Pain Product Introduction
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Medicine for Osteoarthritis Pain
11.10.4 Medicine for Osteoarthritis Pain Product Introduction
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.12 TEVA
11.13 Almatica Pharma
11.14 Astellas Pharma
11.15 Tide Pharmaceutical
11.16 Iroko Pharmaceuticals
11.17 Hengrui Pharmaceutical
11.18 Abiogen Pharma
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Medicine for Osteoarthritis Pain Sales Channels
12.2.2 Medicine for Osteoarthritis Pain Distributors
12.3 Medicine for Osteoarthritis Pain Customers
13 Market Forecast
13.1 Global Medicine for Osteoarthritis Pain Sales and Revenue Forecast 2018-2025
13.2 Global Medicine for Osteoarthritis Pain Sales Forecast by Type
13.3 Global Medicine for Osteoarthritis Pain Sales Forecast by Application
13.4 Medicine for Osteoarthritis Pain Forecast by Regions
13.4.1 Global Medicine for Osteoarthritis Pain Sales Forecast by Regions 2018-2025
13.4.2 Global Medicine for Osteoarthritis Pain Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Medicine for Osteoarthritis Pain Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Medicine for Osteoarthritis Pain Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Medicine for Osteoarthritis Pain Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Medicine for Osteoarthritis Pain Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Medicine for Osteoarthritis Pain Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma
【免責事項】
https://www.globalresearch.jp/disclaimer